Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis

Authors:
  • GBGerald J. Beck
    Gerald J. Beck
  • MAMichael Allon
    Michael Allon
  • JDJames A. Delmez
    James A. Delmez
  • AGArthur Greenberg
    Arthur Greenberg
  • JHJonathan Himmelfarb
    Jonathan Himmelfarb
  • MVMiguel A. Vazquez
    Miguel A. Vazquez
  • JGJennifer J. Gassman
    Jennifer J. Gassman
  • TGTom Greene
    Tom Greene
  • MRMilena K. Radeva
    Milena K. Radeva
  • GBGregory L. Braden
    Gregory L. Braden

Top Cited Papers
Open Access
Abstract
Approximately 470 000 Americans have end-stage renal disease, and most are treated with hemodialysis.1 A major challenge in caring for patients undergoing hemodialysis is maintaining a functioning vascular access, which is essential for performing the dialysis procedure. The effect of vascular access dysfunction is substantial—it is a leading reason for hospitalization among patients with end-stage renal disease and has associated annual costs in the United States that exceed $1 billion.2,3

This publication has 17 references indexed in Scilit: